S&P 500   3,963.51
DOW   33,781.48
QQQ   283.85
101 Christmas Gift Ideas Under $40
The Safest Option in Trades! (Ad)pixel
This Is Why Daktronics Fell 40% In One Day 
Why You Should Avoid Carvana Even if it Avoids Bankruptcy
The Safest Option in Trades! (Ad)pixel
The Question of a Fed Pivot Isn't If, It's When, Here's Why
On the money: Yellen's next milestone is name on US currency
The Safest Option in Trades! (Ad)pixel
Biden releasing nearly $36B to aid pensions of union workers
Are Investors Hearing The End Of Spotify's Downtrend?
S&P 500   3,963.51
DOW   33,781.48
QQQ   283.85
101 Christmas Gift Ideas Under $40
The Safest Option in Trades! (Ad)pixel
This Is Why Daktronics Fell 40% In One Day 
Why You Should Avoid Carvana Even if it Avoids Bankruptcy
The Safest Option in Trades! (Ad)pixel
The Question of a Fed Pivot Isn't If, It's When, Here's Why
On the money: Yellen's next milestone is name on US currency
The Safest Option in Trades! (Ad)pixel
Biden releasing nearly $36B to aid pensions of union workers
Are Investors Hearing The End Of Spotify's Downtrend?
S&P 500   3,963.51
DOW   33,781.48
QQQ   283.85
101 Christmas Gift Ideas Under $40
The Safest Option in Trades! (Ad)pixel
This Is Why Daktronics Fell 40% In One Day 
Why You Should Avoid Carvana Even if it Avoids Bankruptcy
The Safest Option in Trades! (Ad)pixel
The Question of a Fed Pivot Isn't If, It's When, Here's Why
On the money: Yellen's next milestone is name on US currency
The Safest Option in Trades! (Ad)pixel
Biden releasing nearly $36B to aid pensions of union workers
Are Investors Hearing The End Of Spotify's Downtrend?
S&P 500   3,963.51
DOW   33,781.48
QQQ   283.85
101 Christmas Gift Ideas Under $40
The Safest Option in Trades! (Ad)pixel
This Is Why Daktronics Fell 40% In One Day 
Why You Should Avoid Carvana Even if it Avoids Bankruptcy
The Safest Option in Trades! (Ad)pixel
The Question of a Fed Pivot Isn't If, It's When, Here's Why
On the money: Yellen's next milestone is name on US currency
The Safest Option in Trades! (Ad)pixel
Biden releasing nearly $36B to aid pensions of union workers
Are Investors Hearing The End Of Spotify's Downtrend?
NASDAQ:OMCL

Omnicell - OMCL Price Target & Analyst Ratings

$48.12
-0.02 (-0.04%)
(As of 12/8/2022 12:00 AM ET)
Add
Compare
Today's Range
$47.55
$49.68
50-Day Range
$46.24
$90.03
52-Week Range
$46.19
$185.28
Volume
713,477 shs
Average Volume
530,913 shs
Market Capitalization
$2.13 billion
P/E Ratio
47.18
Dividend Yield
N/A
Price Target
$82.44

Omnicell Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 8 Analyst Ratings

Consensus Analyst Price Target

$82.44
71.33% Upside
High Prediction$157.00
Average Prediction$82.44
Low Prediction$54.00
TypeCurrent
12/9/21 to 12/9/22
1 Month Ago
11/9/21 to 11/9/22
3 Months Ago
9/10/21 to 9/10/22
1 Year Ago
12/9/20 to 12/9/21
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
5 Buy rating(s)
5 Buy rating(s)
5 Buy rating(s)
Hold
3 Hold rating(s)
2 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$82.44$85.63$155.33$190.83
Predicted Upside71.33% Upside35.40% Upside29.58% Upside15.82% Upside
Get Omnicell Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for OMCL and its competitors with MarketBeat's FREE daily newsletter.


OMCL Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

OMCL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Omnicell Stock vs. The Competition

TypeOmnicellMedical CompaniesS&P 500
Consensus Rating Score
2.63
2.66
2.48
Consensus RatingModerate BuyBuyHold
Predicted Upside71.33% Upside682.24% Upside14.89% Upside
News Sentiment RatingNeutral News
Neutral News
Neutral News
MarketBeat
Community Rating
Outperform Votes
484
70.25%
Underperform Votes
205
29.75%
Avg. Outperform Votes
163
66.26%
Avg. Underperform Votes
83
33.74%
Avg. Outperform Votes
853
68.13%
Avg. Underperform Votes
399
31.87%

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/18/2022JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral$140.00 ➝ $57.00+7.28%
11/4/2022Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$158.00 ➝ $71.00+34.67%
11/3/2022Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$185.00 ➝ $75.00+50.00%
11/3/2022Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
11/3/2022BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$160.00 ➝ $75.00+50.00%
11/3/2022KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$130.00 ➝ $75.00+50.00%
11/3/2022SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Zhang
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetMarket Perform$117.00 ➝ $54.00+8.00%
11/2/2022Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$145.00 ➝ $58.00+15.98%
9/9/2022Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$120.00+17.86%
12/8/2020Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy
12/3/2020Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Halper
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Neutral$95.00-12.18%
7/6/2020Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOverweight$90.00+34.51%
2/7/2020Dougherty & Co
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$92.00 ➝ $100.00+11.96%
(Data available from 12/9/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












OMCL Price Target - Frequently Asked Questions

What is Omnicell's consensus rating and price target?

According to the issued ratings of 8 analysts in the last year, the consensus rating for Omnicell stock is Moderate Buy based on the current 3 hold ratings and 5 buy ratings for OMCL. The average twelve-month price prediction for Omnicell is $82.44 with a high price target of $157.00 and a low price target of $54.00. Learn more on OMCL's analyst rating history.

Do Wall Street analysts like Omnicell more than its competitors?

Analysts like Omnicell less than other Medical companies. The consensus rating for Omnicell is Moderate Buy while the average consensus rating for medical companies is Buy. Learn more on how OMCL compares to other companies.

Do MarketBeat users like Omnicell more than its competitors?

MarketBeat users like Omnicell more than other Medical companies. 70.25% of MarketBeat users gave Omnicell an outperform vote while medical companies recieve an average of 66.26% outperform votes by MarketBeat users.

Is Omnicell being downgraded by Wall Street analysts?

Over the previous 90 days, Omnicell's stock had 1 downgrade by analysts.

Does Omnicell's stock price have much upside?

According to analysts, Omnicell's stock has a predicted upside of 33.03% based on their 12-month price targets.

What analysts cover Omnicell?

Stock Ratings Reports and Tools

This page (NASDAQ:OMCL) was last updated on 12/9/2022 by MarketBeat.com Staff